Inhibrx (INBX) Stock Closed Higher After Asset Sale Deal
Inhibrx, Inc. (NASDAQ: INBX) stocks surged by 8.91%, reaching a closing price of $36.30. This upward trend was triggered by a transaction involving the sale of company assets. Today, Inhibrx (INBX) and Sanofi declared the finalization of a strategic partnership. Under the agreement, Sanofi’s subsidiary Aventis Inc. will take over all assets and liabilities related […]